Orphan Drugs: In Development
DISEASE DRUG NAME COMPANY INDICATION Hyperphosphatemia Phos-Lo~ Braintree Laboratories treatment of hyperphosphatemia in end-stage calcium acetate (Braintree, MA) renal failure Hypocalcemia Parathar~ Rhone-Poulenc Rorer diagnostic agent to assist in establishing the teriparatide (Collegeville, PA) diagnosis in patients presenting with clinical and laboratory evidence of hypocalcemia due to either hypoparathyroidism or pseudohypoparathyroidism Hypocitraturia Urocit-K~ Mission Pharmacal control and prevention of calcium renal stones in potassium citrate (San Antonio, TX) patients with hypocitraturia Keratoconjunctivitis, Opticrom~t Fisons Corporation treatment of vernal keratoconjunctivitis Vernal cromolyn sodium 4% (Rochester, NY) ophthalmic solution Lead Poisoning ChemetTM McNeil Consumer Products treatment of lead poisoning in children succimer (Spring House, PA) Leprosy Lamprene~ CIBA-GEIGY treatment of lepromatous leprosy, including that clofazimine (Summit, NJ) which is dapsone-resistant and that which is complicated by erythema nodosum leprosum Leukapheresis Pentaspan~ Du Pont Merck adjunct in leukapheresis to improve the harvesting pentastarch (Wilmington, DE) and increase the yield of leukocytes by centrifugal means Malaria Lariam~ Hoffmann-La Roche prophylaxis of Plasmodium falciparum malaria mefloquine HCL (Nutley, NJ) that is resistant to other available drugs Lariam~ Hoffmann-La Roche treatment of acute malaria due to Plasmodium mefloquine HCL (Nutley, NJ) falciparum and Plasmodium vivax Mastocytosis Gastrocom~ Fisons Corporation treatment of mastocytosis cromolyn sodium (Rochester, NY) Nephrolithiasis Renacidin~ Irrigation United-Guardian treatment of renal and bladder calculi of the citric acid, glucono- (Smithtown, NY) apatite or struvite variety delta-lactone, magnesium carbonate Thiola~ Mission Pharmacal control and prevention of cystine nephrolithiasis tiopronin (San Antonio, TX) in patients with homozygous cystinuria Urocit-K~ Mission Pharmacal control and prevention of uric acid nephrolithiasis potassium citrate (San Antonio, TX) Urocit-K~ Mission Pharmacal avoidance of the complication of calcium stone potassium citrate (San Antonio, TX) formation in patients with uric lithiasis Neutropenia Leukine~ Immunex treatment of neutropenia associated with bone sargramostim (Seattle, WA) marrow transplantation in patients with nonHodgkin's lymphoma, Hodgkin's disease and ALL Opioid Dependency TrexanMt Du Pont Merck blockade of the pharmacological effects of naltrexone HCL (Wilmington, DE) exogenously administered opioids as an adjunct to the maintenance of the opioid-free state in detoxified formerly opioid-dependent individuals Paget's Disease Cibacalcin~ CIBA-GEIGY treatment of symptomatic Paget's disease of bone calcitonin-human (Summit, NJ) (osteitis deformans) Pain InfumorphTM Elkins-Sinn for use in microinfusion devices for intraspinal preservative-free (Cherry Hill, NJ) administration in the treatment of intractable morphine sulfate chronic pain solution Parkinson's Disease Eldepryl~ Somerset adjuvant to levodopa and carbidopa treatment of selegiline HCL (Denville, NJ) idiopathic Parkinson's disease (paralysis agitans), post-encephalitic parkinsonism, and symptomatic parkinsonism Pneumocystis Carinii NebuPent~ Fujisawa prevention of PCP in patients at high risk of Pneumonia (PCP) pentamidine isethionate (Deerfield, IL) developing this disease Pentam~ 300t Fujisawa treatment of PCP pentamidine isethionate (Deerfield, IL) Polycystic Ovarian Metrodin~ Serono Laboratories induction of ovulation in patients with polycystic Disease urofollitropin (Norwell, MA) ovarian disease who have an elevated LH/FSH for injection ratio and who have failed to respond to adequate clomiphene citrate therapy 17
About this Item
- Title
- Orphan Drugs: In Development
- Author
- Pharmaceutical Research and Manufacturers of America
- Canvas
- Page 17
- Publication
- Pharmaceutical Manufacturers Association.
- 1992
- Subject terms
- reports
- Series/Folder Title
- Marketplace > Press releases, reports, and newsletters
- Item type:
- reports
Technical Details
- Collection
- Jon Cohen AIDS Research Collection
- Link to this Item
-
https://name.umdl.umich.edu/5571095.0504.010
- Link to this scan
-
https://quod.lib.umich.edu/c/cohenaids/5571095.0504.010/17
Rights and Permissions
The University of Michigan Library provides access to these materials for educational and research purposes, with permission from their copyright holder(s). If you decide to use any of these materials, you are responsible for making your own legal assessment and securing any necessary permission.
Related Links
IIIF
- Manifest
-
https://quod.lib.umich.edu/cgi/t/text/api/manifest/cohenaids:5571095.0504.010
Cite this Item
- Full citation
-
"Orphan Drugs: In Development." In the digital collection Jon Cohen AIDS Research Collection. https://name.umdl.umich.edu/5571095.0504.010. University of Michigan Library Digital Collections. Accessed June 10, 2025.